The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: Results from the Women's Health Initiative randomized controlled trials

Journal of Hypertension

Volumn 32, Issue 10, 2014, Pages 2071-2081

  Shimbo, Daichi ^a   Wang, Lu ^b   Lamonte, Michael J ^c   Allison, Matthew ^d   Wellenius, Gregory A ^e   Bavry, Anthony A ^f   Martin, Lisa W ^g   Aragaki, Aaron ^h   Newman, Jonathan D ^a   Swica, Yael ^a   Rossouw, Jacques E ⁱ   Manson, Jo Ann E ^b   Wassertheil Smoller, Sylvia ^j  

^a Medical Center ^*  (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BROWN UNIVERSITY   (United States)

^f UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^g GEORGE WASHINGTON UNIVERSITY   (United States)

^h USA   (United States)

ⁱ NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^j ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Blood pressure; Hormone therapy; Hypertension; Postmenopause; Women

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CONJUGATED ESTROGEN; DIURETIC AGENT; MEDROXYPROGESTERONE ACETATE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE VARIABILITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HORMONAL THERAPY; HUMAN; HYPERTENSION; MEAN ARTERIAL PRESSURE; MEDICATION COMPLIANCE; MIDDLE AGED; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SMOKING; SYSTOLIC BLOOD PRESSURE; VASOMOTOR DISORDER; VISIT TO VISIT BLOOD PRESSURE VARIABILITY; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; DRUG EFFECTS; ESTROGEN THERAPY; WOMEN'S HEALTH;

AGED; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; POSTMENOPAUSE; WOMEN'S HEALTH;

EID: 84921310915     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000287     Document Type: Article

References (37)

1. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333.
2. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291:1701-1712.
3. Rossouw JE, Manson JE, Kaunitz AM, Anderson GL. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy. Obstet Gynecol 2013; 121:172-176.
4. Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet 2007; 370:591-603.
5. Morley Kotchen J, Kotchen TA. Impact of female hormones on blood pressure: review of potential mechanisms and clinical studies. Curr Hypertens Rep 2003; 5:505-512.
6. Saleh TM, Connell BJ. Role of oestrogen in the central regulation of autonomic function. Clin Exp Pharmacol Physiol 2007; 34:827-832.
7. Miura S, Tanaka E, Mori A, Toya M, Takahashi K, Nakahara K, et al. Hormone replacement therapy improves arterial stiffness in normotensive postmenopausal women. Maturitas 2003; 45:293-298.
8. Chiu CL, Lujic S, Thornton C, O'Loughlin A, Makris A, Hennessy A, et al. Menopausal hormone therapy is associated with having high blood pressure in postmenopausal women: observational cohort study. PLoS One 2012; 7:e40260.
9. Karalis I, Beevers G, Beevers M, Lip G. Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension. Blood Press 2005; 14:38-44.
10. Scuteri A, Bos AJ, Brant LJ, Talbot L, Lakatta EG, Fleg JL. Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women. Ann Intern Med 2001; 135:229-238.
11. Wassertheil-Smoller S, Anderson G, Psaty BM, Black HR, Manson J, Wong N, et al. Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative. Hypertension 2000; 36:780-789.
12. Ichikawa J, Sumino H, Ichikawa S, Ozaki M. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women. Am J Hypertens 2006; 19:744-749.
13. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlof B, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375:895-905.
14. Shimbo D, Newman JD, Aragaki AK, LaMonte MJ, Bavry AA, Allison M, et al. Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: Data from the Women's Health Initiative. Hypertension 2012; 60:625-630.
15. Szekacs B, Vajo Z, Acs N, Hada P, Csuzi L, Bezeredi J, et al. Hormone replacement therapy reduces mean 24-h blood pressure and its variability in postmenopausal women with treated hypertension. Menopause 2000; 7:31-35.
16. Kawecka-Jaszcz K, Czarnecka D, Olszanecka A, Rajzer M, Jankowski P. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension. J Hum Hypertens 2002; 16:509-516.
17. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials 1998; 19:61-109.
18. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 2011; 57:160-166.
19. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensivedrug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 2010; 375:906-915.
20. Cui JS, Hopper JL, Harrap SB. Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension 2003; 41:207-210.
21. Team DC. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2010.
22. Scott AR, Dhindsa P, Forsyth J, Mansell P. Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes. Diabetes Obes Metab 2004; 6:16-22.
23. Steiner AZ, Hodis HN, Lobo RA, Shoupe D, Xiang M, Mack WJ. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial. Menopause 2005; 12:728-733.
24. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350:757-764.
25. Harman SM, Manson JE. New findings from the Kronos Early Prevention Study (KEEPS) Randomized Trial. 2012; http://www.menopause. org/annual-meetings/2012-meeting/keeps-report. [Accessed 1 April 2014].
26. El-Mas MM, Abdel-Rahman AA. Longitudinal assessment of the effects of oestrogen on blood pressure and cardiovascular autonomic activity in female rats. Clin Exp Pharmacol Physiol 2009; 36:1002-1009.
27. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies C. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
28. Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 2012; 308:875-881.
29. Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens 2011; 5:184-192.
30. Shimbo D, Shea S, McClelland RL, Viera AJ, Mann D, Newman J, et al. Associations of aortic distensibility and arterial elasticity with long-term visit-to-visit blood pressure variability: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens 2013; 26:896-902.
31. Bui MN, Arai AE, Hathaway L, Waclawiw MA, Csako G, Cannon RO 3rd. Effect of hormone replacement therapy on carotid arterial compliance in healthy postmenopausal women. Am J Cardiol 2002; 90:82-85.
32. Angerer P, Kothny W, Stork S, von Schacky C. Hormone replacement therapy and distensibility of carotid arteries in postmenopausal women: a randomized, controlled trial. J Am Coll Cardiol 2000; 36:1789-1796.
33. Tatchum-Talom R, Martel C, Marette A. Influence of estrogen on aortic stiffness and endothelial function in female rats. Am J Physiol Heart Circ Physiol 2002; 282:H491-H498.
34. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005; 111:697-716.
35. Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, et al. The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology 2005; 25:135-143.
36. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, et al. Multiethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002; 156:871-881.
37. Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright JT Jr, Cushman WC, et al. Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens 1996; 9 (4 Pt 1):342-360